These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22293236)

  • 1. Design-for-Six-Sigma for Development of a Bioprocess Quality-by-Design Framework.
    Junker B; Kosinski M; Geer D; Mahajan R; Chartrain M; Meyer B; Dephillips P; Wang Y; Henrickson R; Ezis K; Waskiewicz M
    PDA J Pharm Sci Technol; 2011; 65(3):254-86. PubMed ID: 22293236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design-for-Six-Sigma To Develop a Bioprocess Knowledge Management Framework.
    Junker B; Maheshwari G; Ranheim T; Altaras N; Stankevicz M; Harmon L; Rios S; D'anjou M
    PDA J Pharm Sci Technol; 2011; 65(2):140-65. PubMed ID: 21502075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality by design (QbD) approaches in current pharmaceutical set-up.
    Mishra V; Thakur S; Patil A; Shukla A
    Expert Opin Drug Deliv; 2018 Aug; 15(8):737-758. PubMed ID: 30044646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical quality by design: product and process development, understanding, and control.
    Yu LX
    Pharm Res; 2008 Apr; 25(4):781-91. PubMed ID: 18185986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-based Process Development of Biosimilars as Part of the Quality by Design Paradigm.
    Zalai D; Dietzsch C; Herwig C
    PDA J Pharm Sci Technol; 2013; 67(6):569-80. PubMed ID: 24265299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets.
    Badawy SI; Narang AS; LaMarche KR; Subramanian GA; Varia SA; Lin J; Stevens T; Shah PA
    J Pharm Sci; 2016 Jan; 105(1):168-81. PubMed ID: 26852852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality by Design in Pharmaceuticals: A Review of its Impact on Regulatory Compliance and Product Quality.
    Nunavath RS; Singh MT; Jain A; Chakma M; Arivuselvam R; Azeeze MSTA
    Drug Res (Stuttg); 2024 Jan; 74(1):18-23. PubMed ID: 38134919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A roadmap for model-based bioprocess development.
    Mu'azzam K; Santos da Silva FV; Murtagh J; Sousa Gallagher MJ
    Biotechnol Adv; 2024; 73():108378. PubMed ID: 38754797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Process Analytical Technologies - Advances in bioprocess integration and future perspectives.
    Gerzon G; Sheng Y; Kirkitadze M
    J Pharm Biomed Anal; 2022 Jan; 207():114379. PubMed ID: 34607168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality by Design: Concept to Applications.
    Swain S; Parhi R; Jena BR; Babu SM
    Curr Drug Discov Technol; 2019; 16(3):240-250. PubMed ID: 29521238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns.
    del Val IJ; Kontoravdi C; Nagy JM
    Biotechnol Prog; 2010; 26(6):1505-27. PubMed ID: 20665659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Information Processing: Rate-Based Investigation of Cell Physiological Changes along Design Space Development.
    Sagmeister P; Wechselberger P; Herwig C
    PDA J Pharm Sci Technol; 2012; 66(6):526-41. PubMed ID: 23183649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roadmap for implementation of quality by design (QbD) for biotechnology products.
    Rathore AS
    Trends Biotechnol; 2009 Sep; 27(9):546-53. PubMed ID: 19647883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical product development: A quality by design approach.
    Pramod K; Tahir MA; Charoo NA; Ansari SH; Ali J
    Int J Pharm Investig; 2016; 6(3):129-38. PubMed ID: 27606256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Product Development, Manufacturing, and Packaging of Solid Dosage Forms Under QbD and PAT Paradigm: DOE Case Studies for Industrial Applications.
    Singh BN
    AAPS PharmSciTech; 2019 Sep; 20(8):313. PubMed ID: 31529232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Process Analytical Technology: Present State in Bioprocessing.
    Jenzsch M; Bell C; Buziol S; Kepert F; Wegele H; Hakemeyer C
    Adv Biochem Eng Biotechnol; 2018; 165():211-252. PubMed ID: 28776065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding pharmaceutical quality by design.
    Yu LX; Amidon G; Khan MA; Hoag SW; Polli J; Raju GK; Woodcock J
    AAPS J; 2014 Jul; 16(4):771-83. PubMed ID: 24854893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of GAMP 5, data integrity and QbD on quality assurance in the pharmaceutical industry: How obvious is it?
    Pedro F; Veiga F; Mascarenhas-Melo F
    Drug Discov Today; 2023 Nov; 28(11):103759. PubMed ID: 37660982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategic framework for education and training in Quality by Design (QbD) and process analytical technology (PAT).
    de Matas M; De Beer T; Folestad S; Ketolainen J; Lindén H; Lopes JA; Oostra W; Weimer M; Öhrngren P; Rantanen J
    Eur J Pharm Sci; 2016 Jul; 90():2-7. PubMed ID: 27112991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Question-based review for pharmaceutical development: An enhanced quality approach.
    Simões A; Veiga F; Vitorino C
    Eur J Pharm Biopharm; 2024 Feb; 195():114174. PubMed ID: 38160986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.